Sort by
Refine Your Search
-
to arrange working at both host institutions (UAntwerp and KU Leuven), located ca. 50 km apart with a direct train connection in-between. What we offer We offer a doctoral scholarship for a period of 1 year
-
to neurodegenerative diseases of the central and peripheral nervous system, with an emphasis on understanding the genetic etiology and developing diagnostics and treatment methods for these diseases. Approaches range
-
within the Antwerp University Hospital and the University of Antwerp, comprising over 50 scientists with a main goal to advance cancer treatment and to improve patient quality of life through development
-
Department: Institute of Development Policy (IOB) Regime Full-time Let’s shape the future - University of Antwerp The University of Antwerp is a dynamic, forward-thinking, European university. We
-
photoelectrochemical sensing applications. By evaluating different quenching mechanisms (e.g., proximity-based singlet oxygen quenching and wavelength-specific energy transfer), this project seeks to develop novel
-
talented PhD students to develop and benchmark cutting-edge super-resolution imaging technologies. The project aims to establish a comprehensive approach for ultra-high-content, multimodal imaging
-
-regulatory network analysis approaches, developed and employed in the Malysheva Lab, are required to reveal these mechanisms. With the proposed project we aim to bridge this gap in our knowledge of cis
-
for doctoral scholarship holders on the pay scales for Contract Research Staff . Opportunities of career development (doctoral training) A stimulating and international research environment You will receive
-
/immunotherapies are insufficient due to resistance development and limited efficacy. Personalized medicine, focusing on novel prognostic and predictive biomarkers to identify patients that will respond to treatment
-
malignancy and is the second leading cause of cancer-related deaths worldwide. Current treatment options such as chemotherapy and targeted/immunotherapies are insufficient due to resistance development and